Summary
President Trump announced a link between Tylenol use during pregnancy and autism rates in the U.S. He also made claims about autism rates in Amish and Cuban populations, suggesting they have lower rates of autism. The evidence for these claims is limited and research into the topic is ongoing.
Key Facts
- President Trump's announcement linked Tylenol during pregnancy to a rise in autism cases.
- The FDA approved leucovorin, a form of vitamin B, for treating children with autism.
- Trump claimed that autism is rare among the Amish and Cuban populations.
- A 2010 study found autism rates in some Amish children, but less than the national average.
- Cuban studies show autism diagnoses, but at lower rates due to limited healthcare infrastructure.
- Research into Tylenol's possible link to autism started gaining attention in the 2010s.
- A 2025 study review showed associations between acetaminophen and autism but didn't confirm causation.
- Experts emphasize more research is needed to understand Tylenol's impact on autism.
